Oncology status update: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Line 1,821: Line 1,821:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Pineal parenchymal tumors (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |Pineal parenchymal tumors (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |Rhabdomyosarcoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,830: Line 1,830:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Pineal teratoma (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |Pineal teratoma (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |Sarcoma (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,838: Line 1,838:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Pineal yolk sac tumor (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |Pineal yolk sac tumor (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |Surface epithelial-stromal tumor (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,848: Line 1,848:
| style="padding: 5px 5px; background: #F5F5F5;" |Pineocytoma (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |Pineocytoma (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
{| class="wikitable"
|-
|Teratoma
|-
|Lipoma
|-
|Liposarcoma
|-
|Myxoma
|-
|PEComa (SP)
|-
|Elastofibroma (SP)
|-
|Epithelioid sarcoma
|-
|Fibroma
|-
|Glomus tumor
|-
|Hamartoma
|-
|Carotid body tumor (SP)
|-
|
|-
|Hypereosinophilic syndrome
|-
|Lung cancer
|-
|Lung mass
|-
|Adenocarcinoma of lung
|-
|Mesothelioma
|-
|Non small cell lung cancer
|-
|Pulmonary nodule
|-
|Sarcomatoid carcinoma of the lung (SP)
|-
|Small cell lung cancer
|-
|Superior vena cava syndrome
|-
|Large cell carcinoma of the lung
|-
|Squamous cell carcinoma of the lung
|-
|
|-
|Kaposi's sarcoma
|-
|Desmoid tumor
|-
|Basal cell carcinoma
|-
|Dermatofibroma
|-
|Dysplastic nevus
|-
|Erythema gyratum repens
|-
|Melanocytic nevus
|-
|Melanoma
|-
|Merkel cell cancer
|-
|Skin cancer (LP)
|-
|Squamous cell carcinoma of the skin
|-
|Subcutaneous panniculitis-like T-cell lymphoma (SP)
|-
|Verrucous carcinoma (SP)
|-
|Primary cutaneous follicle centre lymphoma
|-
|Dermoid cyst
|-
|Cutaneous T cell lymphoma (LP)
|-
|Sezary syndrome
|-
|Mycosis fungoides
|-
|
|-
|Adrenal carcinoma (LP)
|-
|Adrenal metastases (SP)
|-
|
|-
|Adrenocortical carcinoma
|-
|Follicular thyroid cancer
|-
|Glucagonoma
|}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,967: Line 1,873:
| style="padding: 5px 5px; background: #F5F5F5;" |Schwannoma (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |Schwannoma (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
{| class="wikitable"
|-
|Insulinoma
|-
|Multiple endocrine neoplasia (LP)
|-
|Multiple endocrine neoplasia type 1
|-
|Multiple endocrine neoplasia type 2
|-
|Neuroendocrine tumor (LP)
|-
|Paraganglioma/Pheochromocytoma
|-
|Paraneoplastic syndrome (LP)
|-
|Parathyroid adenoma
|-
|Prolactinoma
|-
|Thymic carcinoma
|-
|Thymoma
|-
|Thyroid adenoma
|-
|
|-
|Giant cell tumor of bone (SP)
|-
|Primary lymphoma of the bone (SP)
|-
|Sacrococcygeal teratoma
|-
|Synovial sarcoma
|-
|Adamantinoma
|-
|Chondroblastoma (SP)
|-
|Chondroma
|-
|Chondrosarcoma
|}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,079: Line 1,941:
| style="padding: 5px 5px; background: #F5F5F5;" |Rhabdomyoma
| style="padding: 5px 5px; background: #F5F5F5;" |Rhabdomyoma
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
{| class="wikitable"
|-
|Ewing's sarcoma
|-
|Osteochondroma
|-
|Osteoblastoma
|-
|Osteoid Osteoma
|-
|Osteoma (SP)
|-
|Osteosarcoma
|-
|Aneurysmal bone cyst
|-
|Simple bone cyst (SP)
|-
|Non ossifying fibroma (NOF)
|-
|Fibrous dysplasia
|-
|Chondromyxoid Fibroma
|-
|Langerhans cell histiocytosis (Eosinophilic granuloma)
|-
|Palmar plantar erythrodysesthesia
|-
|Angiomyolipoma
|-
|Angiosarcoma
|-
|
|-
|
|-
|Acinic cell carcinoma
|-
|Cementoblastoma (SP)
|-
|Ameloblastoma
|-
|Hemangioendothelioma
|-
|Intravascular large B-cell lymphoma
|-
|Hemangioma
|-
|Hemangiopericytoma
|}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,135: Line 1,947:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Rhabdomyosarcoma
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
| style="padding: 5px 5px; background: #F5F5F5;" |<br />
{| class="wikitable"
|-
|Biliary cystadenoma and cystadenocarcinoma
|-
|Cancer of unknown primary origin (SP)
|-
|Extranodal NK-T-cell lymphoma
|-
|Head and neck cancer (LP)
|-
|
|-
|Intravenous leiomyomatosis
|-
|Low grade astrocytoma
|-
|Tumor lysis syndrome
|-
|
|-
|Bladder cancer
|-
|Malignant rhabdoid tumor
|-
|Renal cell carcinoma
|-
|Renal oncocytoma
|-
|Transitional cell carcinoma
|-
|Urethral cancer
|-
|Wilms' tumor
|-
|Radiation proctitis
|-
|Tier 2 Hematologic malignancies
|-
|Aggressive NK-cell leukemia (SP)
|}




{| class="wikitable"
|-
|Angioimmunoblastic T-cell lymphoma (SP)
|-
|Blastic NK cell lymphoma
|-
|Lymphangitis carcinomatosa (SP)
|-
|Myeloproliferative neoplasm
|-
|Nodular regenerative hyperplasia (SP)
|-
|T-cell large granular lymphocyte leukemia (SP)
|-
|Post transplant lymphoproliferative disorder
|-
|Lymphoid leukemia
|-
|Granulocytic sarcoma
|-
|Lymphoplasmacytic lymphoma
|-
|Erythroleukemia
|-
|Bannayan-Riley-Ruvalcaba syndrome
|-
|B-cell lymphoma (LP)
|-
|Differential Diagnosis (Oncology)
|-
|Lymphoma
|-
|Leukemia
|-
|Myelodysplastic syndrome
|-
|Myeloproliferative neoplasm
|-
|Neuroendocrine Tumor
|-
|Lung mass
|}
{| class="wikitable"
|-
|Pulmonary nodule
|-
|Heart mass
|-
|Oral lesion
|-
|Esophageal cancer
|-
|Gastric cancer
|-
|Liver mass
|-
|Colon cancer
|-
|Rectal mass
|-
|Kidney mass
|-
|Bladder mass
|-
|Breast lumps
|-
|Scrotal swelling
|-
|Pelvic mass
|-
|Vaginal/vulvar mass
|-
|Mediastinal Mass
|-
|Abnormal uterine bleeding/Cervical cancer)
|-
|Endometrial cancer
|-
|Skin cancer
|-
|Testicular cancer
|-
|Head and Neck mass
|-
|Thyroid nodule
|-
|Adrenal mass
|-
|Brain mass
|-
|LP germ cell tumir
|-
|LP sex cord tumor
|}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,280: Line 1,958:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sarcoma (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,288: Line 1,966:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Surface epithelial-stromal tumor (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,297: Line 1,975:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Teratoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,305: Line 1,983:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Lipoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,314: Line 1,992:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Liposarcoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,322: Line 2,000:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Myxoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,331: Line 2,009:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |PEComa (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 2,339: Line 2,017:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elastofibroma (SP)
 
Epithelioid sarcoma
 
Fibroma
 
Glomus tumor
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |

Revision as of 06:31, 3 July 2020

System leader: Farima Kahe, M.D.

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Oncology

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Oncology

Completed chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Oncology Acute lymphoblastic leukemia
Acute myeloid leukemia
Acute promyelocytic leukemia
Adult T-cell leukemia
Anaplastic large cell lymphoma
Burkitt's lymphoma
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic neutrophilic leukemia
Diffuse large B cell lymphoma
Follicular lymphoma
Hairy cell leukemia
Hodgkin's lymphoma
Leukemia (LP)
Leukocytosis (SP)
Hemophilia
Lymphadenopathy
Lymphangioma
Lymphangiomyomatosis (SP)
Lymphangiosarcoma (SP)
Lymphoma (LP)
Lymphomatoid granulomatosis
Mast cell leukemia
Mast cell tumor
Multiple myeloma
Myelodysplastic syndrome
Myelofibrosis
Nodal marginal zone lymphoma
Non-Hodgkin lymphoma (LP)
Polycythemia vera
Primary effusion lymphoma
Primary mediastinal large B-cell lymphoma (SP)
Prolymphocytic leukemia (LP)
T cell prolymphocytic leukemia (SP)
B cell prolymphocytic leukemia (SP)
Splenic marginal zone lymphoma
Enteropathy-associated T-cell lymphoma
T-cell lymphoma (LP)
Waldenström's macroglobulinemia
Hepatosplenic T cell lymphoma
Hypopharyngeal cancer
Laryngeal cancer
Oral cancer
Salivary gland tumor (LP)
Tongue cancer
Pleomorphic adenoma
Mucoepidermoid carcinoma
Nasopharyngeal angiofibroma (SP)
Nasopharyngeal carcinoma
Warthin's tumor
Appendix cancer
Blue rubber bleb nevus syndrome
Carcinoid syndrome
Cholangiocarcinoma
Colorectal cancer
Desmoplastic small round cell tumor (SP)
Esophageal cancer
Familial adenomatous polyposis
Fibrolamellar hepatocellular carcinoma (SP)
Gallbladder cancer
Gastrointestinal stromal tumor
Hepatoblastoma
Hepatocellular adenoma
Hepatocellular carcinoma
Hereditary nonpolyposis colorectal cancer
Liver mass
MALT lymphoma
Mantle cell lymphoma
Pancreatic cancer
Pancreatic islet cell carcinoma
Peutz-Jeghers syndrome
Pseudomyxoma peritonei (SP)
Small intestine cancer
Stomach cancer
Villous adenoma (SP)
VIPoma
Zollinger-Ellison syndrome
Peritoneal carcinomatosis (SP)
Breast cancer
Breast lumps
Cervical cancer
Cervical intraepithelial neoplasia (SP)
Cervical polyp (SP)
Endodermal sinus tumor
Endometrial cancer
Endometrial hyperplasia
Endometrial intraepithelial neoplasia (SP)
Gestational trophoblastic neoplasia
Ovarian cancer (LP)
Epithelial ovarian tumors
Ovarian germ cell tumor
Sexcord/ stromal ovarian tumor
Krukenberg tumor (SP)
Meigs syndrome (SP)
Ovarian Sarcoma
Leiomyoma (SP)
Leiomyosarcoma
Mixed Mullerian tumor (SP)
Mucinous cystadenocarcinoma
Primary peritoneal cancer (SP)
Vaginal cancer
Vulvar cancer
Adrenolipoma (SP)
Extramammary Paget's disease
Fibroadenoma
Paget's disease of the breast
Atrial myxoma
Germinoma
Gonadoblastoma (SP)
Mediastinal mass
Sarcoma botryoides (SP)
Prostate cancer
Scrotal mass
Seminoma
Testicular cancer
Erythroplasia of Queyrat
Carcinoma of the penis
Acoustic neuroma
Atypical teratoid rhabdoid tumor (SP)
Dysembryoplastic neuroepithelial tumor (SP)
Esthesioneuroblastoma (SP)
Glioma (LP)
Ependymoma
Subependymoma (SP)
Ganglioglioma
Oligodendroglioma
Brain Stem gliomas
Optic nerve glioma
Astrocytoma
Fibrillary astrocytoma (SP)
Gemistocytic astrocytoma (SP)
Familial mediterranean fever
Protoplasmic astrocytoma (SP)
Oligoastrocytoma
Glioblastoma multiforme
Pleomorphic xanthoastrocytoma (SP)
Subependymal giant cell astrocytoma
Gliomatosis cerebri
Primary central nervous system lymphoma
Primitive neuroectodermal tumor (SP)
Pineoblastoma (SP)
Ependymoblastoma (SP)

Medulloblastoma
Pituitary tumor (LP)
Pituitary adenoma
Pituitary carcinoma (SP)
Craniopharyngioma
Malignant peripheral nerve sheath tumor
Medulloepithelioma (SP)
Meningioma
Neoplastic meningitis
Neuroblastoma
Neurofibroma (SP)
Oncocytoma
Paraneoplastic cerebellar degeneration (SP)
Pineal gland tumor (LP)
Pineal choriocarcinoma (SP)
Pineal embryonal carcinoma (SP)
Pineal germinoma (SP)
Pineal parenchymal tumors (SP)
Pineal teratoma (SP)
Pineal yolk sac tumor (SP)
Pineocytoma (SP)





Post-chemotherapy cognitive impairment
Schwannoma (LP)
Vestibular tumor (SP)
Neuroma (LP)
Eye neoplasm (LP)
Intraocular lymphoma
Lisch nodule (SP)
Retinoblastoma
Uveal melanoma
Rhabdomyoma
Rhabdomyosarcoma


Sarcoma (SP)
Surface epithelial-stromal tumor (SP)
Teratoma
Lipoma
Liposarcoma
Myxoma
PEComa (SP)
Elastofibroma (SP)

Epithelioid sarcoma

Fibroma

Glomus tumor

Retrieved from "https://www.wikidoc.org/index.php?title=Oncology_status_update&oldid=1621014"